微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | -1.25% | 68.2% | -231.48% | 35/69 | 3.69% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | -0.38% | 83.25% | 96.85% | 60/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | -12% | -618.22% | -97.17% | 61/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | -6.09% | -212.12% | -54.49% | 63/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | -3.94% | -210.77% | -74.57% | 63/69 | 0.66% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | -2.26% | -257.28% | -197.45% | 64/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 2.32% | 116.29% | -57.34% | 51/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 5.43% | -0.26% | 52.63% | 44/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 3.56% | 6.95% | 147.87% | 45/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 1.44% | 0.14% | 110.09% | 52/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | -14.22% | -358.79% | -361.22% | 63/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 5.44% | -36.26% | 63.65% | 41/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 3.33% | -25.33% | 132.1% | 37/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 1.43% | -31.34% | -73.92% | 45/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 5.49% | -5.5% | -35.66% | 43/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 8.54% | 65.2% | 91.72% | 28/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 4.45% | 41.49% | 113.42% | 34/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.09% | 26.64% | -64.1% | 39/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 5.81% | 99.66% | 12.48% | 41/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | 5.17% | 18.23% | 64.2% | 42/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | 3.15% | 11.12% | 91.02% | 38/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 1.65% | -1.67% | -43.41% | 40/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | 2.91% | 114.43% | -33.39% | 51/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 4.37% | -3.68% | 54.32% | 45/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 2.83% | -22.81% | 69.03% | 48/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 1.68% | -28.38% | 108.31% | 48/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | -20.18% | -341.68% | -544.55% | 65/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 4.54% | -41.17% | 23.68% | 46/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 3.67% | -13.52% | 56.84% | 42/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 2.34% | -7.36% | -71.97% | 38/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | 8.35% | -14.92% | 8.2% | 41/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 7.72% | -1.15% | 81.81% | 38/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 4.24% | -12.31% | 68.01% | 42/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 2.53% | 10.69% | -74.26% | 33/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 9.81% | 99.21% | 25.71% | 34/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 7.81% | 69.11% | 61.28% | 33/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 4.84% | 212.06% | 112.09% | 37/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 2.28% | 36.32% | -53.67% | 37/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 4.93% | -65.58% | 6.72% | 52/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 4.62% | -54.64% | 197.61% | 43/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 1.55% | -72.1% | -7.35% | 48/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 1.67% | -17.21% | -88.3% | 39/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |